Glucuronidation of 3′-azido-3′-deoxythymidine catalyzed by human liver UDP-glucuronosyltransferase: Significance of nucleoside hydrophobicity and inhibition by xenobiotics
- 15 July 1991
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 42 (3) , 559-568
- https://doi.org/10.1016/0006-2952(91)90319-z
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Probenecid Inhibits the Metabolic and Renal Clearances of Zidovudine (AZT) in Human VolunteersPharmaceutical Research, 1990
- PROBENECID AND ZIDOVUDINE METABOLISMThe Lancet, 1989
- Glucuronidation of 3'-azido-3'-deoxythymidine: Human and rat enzyme specificityBiochemical Pharmacology, 1989
- Survival Experience Among Patients With AIDS Receiving ZidovudinePublished by American Medical Association (AMA) ,1988
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- The Efficacy of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Toxicity of 3'-azido-3'-deoxythymidine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine for normal human hematopoietic progenitor cells in vitroAntimicrobial Agents and Chemotherapy, 1987
- Inhibition of replication and cytopathic effect of human T cell lymphotropic virus type III/lymphadenopathy-associated virus by 3'-azido-3'-deoxythymidine in vitroAntimicrobial Agents and Chemotherapy, 1986
- ADMINISTRATION OF 3'-AZIDO-3'-DEOXYTHYMIDINE, AN INHIBITOR OF HTLV-III/LAV REPLICATION, TO PATIENTS WITH AIDS OR AIDS-RELATED COMPLEXThe Lancet, 1986
- Clinical Pharmacokinetics of ProbenecidClinical Pharmacokinetics, 1981